MedCity News |
Pathway Genomics responds to FDA's concerns on liquid biopsy test
MedCity News Pathway has an interesting telemedicine model for this – patients can remotely consult with Pathway-sanctioned doctors through video streaming, and then have their blood drawn at home by a Pathway-sanctioned phlebotomist. Something about all of this ... Pathway Genomics' direct-to-consumer cancer diagnostic earns FDA's ire |
from phlebotomist - Google News http://bit.ly/1KPckYQ
No comments:
Post a Comment